Female sex (OR 4.81; 95% CI 2.72-8.51), diabetes (OR 6.57), and obesity (OR 3.82) independently predicted complications of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy.
Observational
What are the predictors of procedural complications following catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy?
Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy carries significant periprocedural risks, particularly in females, diabetics, and obese patients, necessitating careful patient selection.
Effect estimate: OR 4.81 (95% CI 2.72-8.51)
p-value: p=<0.01
<0.01). Independent predictors of complications included female sex (odds ratio OR, 4.81; 95% CI, 2.72-8.51), diabetes mellitus (OR, 6.57; 95% CI, 2.68-16.09) and obesity (OR, 3.82; 95% CI, 1.61-9.06). Conclusions Despite some decline in procedural complications over the years, catheter ablation for AF is still associated with a relatively high periprocedural morbidity and even mortality in patients with HCM. This emphasizes the importance of careful clinical consideration, by an experienced electrophysiologist, in referring patients with HCM for an AF ablation.
Rozen et al. (Tue,) conducted a observational in Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Catheter ablation was evaluated on Procedural complications (OR 4.81, 95% CI 2.72-8.51, p=<0.01). Female sex (OR 4.81; 95% CI 2.72-8.51), diabetes (OR 6.57), and obesity (OR 3.82) independently predicted complications of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: